378
Views
17
CrossRef citations to date
0
Altmetric
Research Article

CD19 Expression and Growth Inhibition of Tumours in Human Multiple Myeloma

, , , , , , & show all
Pages 613-616 | Published online: 01 Jul 2009

  • Kawano, M., Hirano, T., Matsuda, T., et al. (1988) "Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas", Nature 332, 83-85.
  • Suematsu, S., Matsusaka, T., Matsuda, T., et al. (1992) "Generation of plasmacytomas with the chromosomal translocaion t(12;15) in interleukin 6 transgenic mice", Proc. Natl Acad. Sci. USA 89, 232-235.
  • Hilbert, D.M., Kopf, M., Mock, B.A., et al. (1995) "Interleukin 6 is essential for in vivo development of B lineage neoplasms", J. Exp. Med. 182, 243-248.
  • Lattanzio, G., Libert, C., Aquilina, M., et al. (1997) "Defective development of pristine-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice", Am. J. Pathol 151, 689-696.
  • Tedder, T.F., Zhou, L-J. and Engel, P. (1994) "The CD19/CD21 signal transduction complex of B lymphocytes", Immunol. Today 15, 437-442.
  • Harada, H., Kawano, M.M., Huang, N., et al. (1993) "Phenotypic difference of normal plasma cells from mature myeloma cells", Blood 81, 2658-2663.
  • Mahmoud, M.S., Huang, N., Nobuyoshi, M., et al. (1996) "Altered expression of Pax-5 gene in human myeloma cells", Blood 87, 4311-4315.
  • Mahmoud, M.S., Fujii, R., Ishikawa, H., et al. (1999) "Enforced CD19 expression leads to growth inhibition and reduced tumorigenicity", Blood 94, 3551-3558.
  • Lanier, L.L., Testi, R., Bindl, J., et al. (1989) "Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule", J. Exp. Med. 169, 2233-2238.
  • Lanier, L.L., Le, A.M., Ding, A., et al. (1987) "Expression of Leu-19 (NKH-1) antigen on IL-2-dependent cytotoxic and non-cytotoxic T cell lines", J. Immunol. 138, 2019-2023.
  • Matsumoto, A.K., Kopicky-Burd, J., Carter, R. H., et al. (1991) "Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte containing complement receptor type 2 and CD19", J. Exp. Med. 173, 55-64.
  • Bradbury, L.E., Kansas, G.S., Levy, S., et al. (1992) "The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody and Leu-13 molecules", J. Immunol. 149, 2841-2850.
  • Anderson, K.C., Slaughenhoupt, B., Bates, M.P., et al. (1984) "Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation", Blood 63, 1424-1433.
  • Stashenko, P., Nadler, L.M., Hardy, R., et al. (1981) "Expression of cell surface markers after human B lymphocyte activation", Proc. Natl Acad. Sci. USA 78, 3848-3852.
  • Kyle, R.A. and Lust, J.A. (1989) "Monoclonal gammopathies of undetermined significances", Semin. Hematol. 26, 176-200.
  • Kozmik, Z., Wang, S., Dorfler, P., el al. (1992) "The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP", Mol. Cell. Biol. 12, 2662-2672.
  • Gruss, P. and Walther, C. (1992) "Pax in development", Cell 69, 719-722.
  • Urbanek, P., Wang, Z-Q., Fetka, I., et al. (1994) "Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax-5/BSAP", Cell 79, 901-912.
  • Callard, R.E., Rigley, K.P., Smith, S.H., et al. (1992) "CD19 regulation of human B cell responses: B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used", J. Immunol. 148, 2983-2987.
  • Carter, R.H. and Fearon, D.T. (1992) "CD19: Lowering the threshold for antigen receptor stimulation of B lymphocytes", Science 256, 105-107.
  • Rickert, R.C., Rajewsky, K. and Rose, J. (1995) "Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice", Nature 376, 352-355.
  • [221 Fehr, T., Rickert, R.C., Odermatt, B., et al. (1998) "Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19", J. Exp. Med. 188, 145-155.
  • Carter, R.H., Tuveson, D.A., Park, D.J., et al. (1991) "The CD19 complex of B lymphocytes: Activation of phospholipase C by a protein kinase-dependent pathway that can be enhanced by the membrane IgM complex", J. Immunol. 147, 3663-3671.
  • Tuveson, D.A., Carter, R.H., Soltoff, S.P., et al. (1993) "CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase", Science 260, 986-989.
  • O'Rourke, L.M., Tooze, R., Turner, M., et al. (1998) "CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav", Immunity 8, 635-645.
  • Fujimoto, M., Fujimoto, Y., Poe, J.C., et al. (2000) "CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification", Immunity 13, 47-57.
  • Buhl, A.M., Pleiman, C.N., Rickert, R.C., et al. (1997) "Qualitative regulation of B cell antigen receptor signaling by CD19: Selective requirement for P13-kinase activation. inositol-1,4,5-trisphosphate production and Ca2+ mobilization", J. Exp. Med. 186, 1897-1910.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.